Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Scientific Reports|February 3, 2018
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasionHeather K Armstrong, Joanna L Gillis, Ian R D Johnson, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Elife|August 12, 2021
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growthJoanna L Gillis, Josephine A Hinneh, Natalie K Ryan, et al.
Cell Death & Disease|June 2, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancerDanielle Meiwen Fang, Raj K Shrestha, Beatriz German, et al.
Elife|July 21, 2020
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosisZeyad D Nassar, Chui Yan Mah, Jonas Dehairs, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Molecular Cancer Research : MCR|January 17, 2019
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate CancerSeher Balaban, Zeyad D Nassar, Alison Y Zhang, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Cancer Research|August 7, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionLisa M Butler, Chui Yan Mah, Jelle Machiels, et al.
Pageof 5